 Home > Medical News > Latest Medical News > my country's first original ADC new drug Rongchang Biological Vidicuzumab is planned to be included in breakthrough therapy

my country's first original ADC new drug Rongchang Biological Vidicuzumab is planned to be included in breakthrough therapy

 Last Update: 2021-08-16
 Source: Internet
 Author: User

Tags

rohypnol drug

spiriva drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 21, CDE announced that the new indication of Rongchang Bio-Vidi Cetuzumab will be included in a breakthrough treatment product for HER2-positive advanced breasts with liver metastases that have been treated with trastuzumab and taxanes in the past.

Vedicitumumab is an antibody-conjugated drug that contains the human epidermal growth factor receptor-2 (HER2) antibody portion, linker and the cytotoxic drug monomethyl auristatin E (MMAE)

At the beginning of June 2021, at the ASCO annual meeting, the clinical data of vedicitumumab was announced

At present, the indications of vedicitumumab for urothelial cancer have been recognized as a breakthrough therapy in China and the United States.

Data source: Insight database

In the future, Rongchang Bioplans to carry out phase II/III clinical studies for multiple indications in 2021, involving tumor fields such as breast cancer, gastric cancer, NSCLC, and cholangiocarcinoma

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.